Stockreport

Paratek Announces Acceptance of European Marketing Authorization Application for Oral and Intravenous Omadacycline

Paratek Pharmaceuticals, Inc.  (PRTK) 
Last paratek pharmaceuticals, inc. earnings: 2/25 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.paratekpharma.com
PDF -- MAA submission for both community-acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections (ABSSSI) --  -- EMA decision expected se [Read more]